APA (7th ed.) Citation

Stupp, R., Tosoni, A., Bromberg, J. E. C., Hau, P., Campone, M., Gijtenbeek, J., . . . Brandes, A. A. (2011). Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Annals of Oncology, 22(9), 2144. https://doi.org/10.1093/annonc/mdq729

Chicago Style (17th ed.) Citation

Stupp, R., et al. "Sagopilone (ZK-EPO, ZK 219477) for Recurrent Glioblastoma. A Phase II Multicenter Trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group." Annals of Oncology 22, no. 9 (2011): 2144. https://doi.org/10.1093/annonc/mdq729.

MLA (9th ed.) Citation

Stupp, R., et al. "Sagopilone (ZK-EPO, ZK 219477) for Recurrent Glioblastoma. A Phase II Multicenter Trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group." Annals of Oncology, vol. 22, no. 9, 2011, p. 2144, https://doi.org/10.1093/annonc/mdq729.